SUBSCRIBE
SUBSCRIBE
News   Deals

Pfizer Inc. Eyes Germany’s MediGene, Inc. According to Sources

May 14, 2008 | 
1 min read

FRANKFURT, May 14 (Reuters) - U.S. drugmaker Pfizer is exploring acquisition possibilities in the German biotech sector and has held talks with the management of Munich-based MediGene, two industry sources said.

Mergers & acquisitions Europe
Pfizer
MORE ON THIS TOPIC
Business
Dispatches From JPM, Biogen’s Sage Buyout Offer, Pfizer’s Obesity Play, More
January 15, 2025
 · 
1 min read
 · 
Heather McKenzie
Pictured: Aerial view of the San Francisco skyline
Pipeline
JPM25 Day Two: Roche, Amgen, Merck, Lilly and Biogen
January 15, 2025
 · 
4 min read
 · 
Tristan Manalac
The Gariep Dam overflowing. The dam is the largest in South Africa. It is in the Orange River on the border between the Free State and Eastern Cape Provinces. Monochrome
Deals
Biopharma Deals Start Flowing at JPM25—With One Dwarfing Last Year’s Activity
January 14, 2025
 · 
3 min read
 · 
Annalee Armstrong
Trendy halftone collage. Concept of contracting, negotiation, contracting, favorable terms. Trendy modern retro illustration on business theme. Concept of teamwork. Vector illustration
Gene therapy
Regenxbio Jumps on Potential $800M Rare Disease Deal With Nippon Shinyaku
January 14, 2025
 · 
2 min read
 · 
Tristan Manalac